In terms of regulation 5(4) of the Control of Concentrations Regulations, 2002 published in Legal Notice 294 of 2002, the Director General of the Office for Competition notifies for general information that a notification of a concentration between Medina Healthcare Limited (Attard, Malta) and Pharma-Cos Limited (St.Venera, Malta) was filed on Wednesday, 15 September 2021.
The nature of the concentration is an acquisition of sole control by Medina Healthcare Limited of Pharma-Cos Limited.
Medina Healthcare Limited and Pharma-Cos Limited are both involved primarily in the business of importation and sales of medical equipment and supplies, pharmaceutical products and personal care products. Medina Healthcare Limited is also involved in the importation and distribution of protective garments and shoes used in healthcare facilities. Pharma-Cos Limited is also involved in the importation and retail of fashion footwear products in Malta, however this is excluded from the transaction.
The Director General of the Office for Competition invites interested third parties to submit their written objections on this notified concentration within seven days following publication of this notice at the following address: